Loading
No insider purchase over the last 90 days. The latest, by Björn Wullt, was filed 17 Mar 2020.
Selectimmun is a listed company. Its directors and officers file their transactions with Finansinspektionen. No insider at Selectimmun has published a filing in the past twelve months. The most recent one dates from 17 March 2020.
Over the whole record (from 2019), the tally stands at 5 purchases and no sales.
This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
5 of 5 declarations
Selectimmun is a company listed on the XSTO market. It specializes in the development of immunological solutions.